Merck (MRK) Announces Spinoff of Women�s Health, Trusted Legacy Brands and Biosimilars Products

Go back to Merck (MRK) Announces Spinoff of Women�s Health, Trusted Legacy Brands and Biosimilars Products

Merck (MRK) Tops Q4 EPS by 1c, Offers FY Guidance

February 5, 2020 6:49 AM EST

Merck (NYSE: MRK) reported Q4 EPS of $1.16, $0.01 better than the analyst estimate of $1.15. Revenue for the quarter came in at $11.9 billion versus the consensus estimate of $11.98 billion.

GUIDANCE:

Merck sees FY2020 EPS of $5.62-$5.77, versus the consensus of $5.61. Merck sees... More